Segall Bryant & Hamill’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-109,163
Closed -$8.45M – 791
2021
Q3
$8.45M Sell
109,163
-2,508
-2% -$189K 0.08% 241
2021
Q2
$7.99M Buy
111,671
+724
+0.7% +$52.7K 0.08% 244
2021
Q1
$7.51M Sell
110,947
-31,680
-22% -$2.2M 0.07% 258
2020
Q4
$10.4M Buy
142,627
+15,240
+12% +$1.11M 0.12% 190
2020
Q3
$8.97M Buy
127,387
+28,238
+28% +$2.21M 0.12% 182
2020
Q2
$7.2M Buy
99,149
+75,028
+311% +$5.34M 0.12% 174
2020
Q1
$1.49M Buy
24,121
+1,997
+9% +$122K 0.03% 385
2019
Q4
$1.45M Buy
+22,124
New +$1.52M 0.02% 454
2019
Q3
– Sell
-31,505
Closed -$1.82M – 859
2019
Q2
$1.82M Sell
31,505
-13,358
-30% -$783K 0.03% 424
2019
Q1
$2.35M Buy
44,863
+683
+2% +$35.7K 0.04% 382
2018
Q4
$2.34M Buy
44,180
+11,915
+37% +$681K 0.04% 374
2018
Q3
$2.05M Sell
32,265
-10,338
-24% -$669K 0.03% 430
2018
Q2
$2.49M Buy
+42,603
New +$2.31M 0.04% 401

Other funds holding CONE

Segall Bryant & Hamill's CONE Position: Q4 2021 in Review

Segall Bryant & Hamill sold out of CyrusOne Inc Common Stock (CONE) in Q4 2021, closing a stake of 109,163 shares — an estimated $8.45M sold.

Segall Bryant & Hamill first reported a position in CONE in Q2 2018 and held it in 13 quarters. The position peaked at $10.4M in Q4 2020. 469 funds tracked by Wall St. Rank hold CONE as of Q4 2021.

  • Segall Bryant & Hamill reported no remaining CyrusOne Inc Common Stock position as of Q4 2021 after selling out during the quarter.
  • Segall Bryant & Hamill sold 109,163 CyrusOne Inc Common Stock shares in Q4 2021, an estimated $8.45M.
  • Segall Bryant & Hamill first reported a position in CyrusOne Inc Common Stock in Q2 2018 and held it in 13 quarters.
  • Segall Bryant & Hamill's CyrusOne Inc Common Stock position peaked at $10.4M in Q4 2020.
  • 469 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q4 2021.

Based on Segall Bryant & Hamill's 13F filing for Q4 2021, filed 14 Feb 2022.